P

ProQR Therapeutics NV
D

PRQR

2.18000
USD
0.05
(2.35%)
مغلق
حجم التداول
6,607
الربح لكل سهم
-0
العائد الربحي
-
P/E
-6
حجم السوق
229,647,659
أصول ذات صلة
A
ARWR
-0.120
(-0.71%)
16.790 USD
B
BEAM
0.060
(0.30%)
19.950 USD
C
CRSP
0.455
(0.88%)
52.120 USD
E
EDIT
0.02000
(0.78%)
2.57000 USD
F
FATE
0.02000
(1.80%)
1.13000 USD
G
GNFT
0.10000
(2.62%)
3.92000 USD
N
NTLA
-0.020
(-0.19%)
10.710 USD
R
RARE
0.480
(1.21%)
40.000 USD
T
TGTX
0.670
(1.85%)
36.980 USD
المزيد
الأخبار المقالات

العنوان: ProQR Therapeutics NV

القطاع: Healthcare
الصناعة: Biotechnology
ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics.